Critical evaluation of cancer risks in glomerular disease
The increased cancer incidence in patients with glomerular disease can be secondary to an intrinsic immune dysfunction associated with the disease or/and extrinsic factors, especially immunosuppressants.The treatment for paraneoplastic glomerulopathy is different from primary glomerular disease.Immunosuppressive therapy often used for primary glome